Cita APA

Hayashi, H., Nadal, E., Gray, J. E., Ardizzoni, A., Caria, N., Puri, T., & Grohe, C. (2021). Overall treatment strategy for patients with metastatic NSCLC with activating EGFR mutations.

Citación estilo Chicago

Hayashi, Hidetoshi, Ernest Nadal, Jhanelle E. Gray, Andrea Ardizzoni, Nicola Caria, Tarun Puri, y Christian Grohe. Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations. 2021.

Cita MLA

Hayashi, Hidetoshi, et al. Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations. 2021.